Raloxifene Hydrochloride 60 mg

Raloxifene Hydrochloride 60 mg
Product Description

- Presentation: Blisters containing 28 film-coated tablets  

- Indication (Brazil Prescription Medicines): 
1) For the prevention and treatment of osteoporosis;
2) To reduce the risk of breast cancer in postmenopausal womem with osteoporosis.

- Recommended Dosage: 1 tablet once a day   

- Stability Study: 
Zone IV B
(30ºC / 75% RH)  

- Patent Year: 2017  

- Status in Brazil: Approved   

Our finished dosage products are produced, delivered and distributed in Brazil through the Brazilian state-owned laboratories. Blanver fully respects the patents’ expiration dates in all countries.

Blanver Farmoquimica Ltda.

  • BR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Other

Blanver Farmoquimica Ltda.

  • BR
  • 2015
    On CPHI since
  • 1
    Certificates
  • 250 - 499
    Employees
Company types
Other

More Products from Blanver Farmoquimica Ltda. (2)

  • Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    Product Tenofovir Disoproxil Fumarate 300 mg + Emtricitabine 200 mg

    - Presentation: Plastic bottles with 30 coated tablets.  

    - Indication (Brazil Prescription Medicines): 
    1) For PrEP® (pre-exposure prophylaxis), it can help reduce the risk of getting HIV-1 through sex, when taken every day and used together with safer sex practices.
    ...
  • Tenofovir Disoproxil Fumarate

    Product Tenofovir Disoproxil Fumarate

    API - Active Pharmaceutical Ingredient

    - Therapeutic Area: HIV infection and Chronic Hepatitis B
    - Status: DMF (Drug Master File Ready) 

    Blanver fully respects the patents’ expiration dates in all countries

Blanver Farmoquimica Ltda. resources (1)